Anna Veprik

Anna Veprik, PhD, serves as a Senior Clinical Project Manager at Perspectum Ltd, overseeing multiple clinical trials to enhance treatments for metabolic diseases through collaboration with pharmaceutical partners and in-house specialists. Previously, Anna worked as a Senior Research Scientist at Novo Nordisk, leading a high-throughput target discovery program utilizing genome-wide CRISPR screens. Anna's extensive experience includes roles as a Post Doctoral Research Fellow at the University of Oxford, a Research Associate at the Weizmann Institute of Science, and a founder of the ScienceAbroad local chapter. Anna holds a PhD in Biochemistry and Molecular Biology from the Weizmann Institute of Science, as well as a Master’s Degree from Ben-Gurion University of the Negev and a B.A. from the Technion - Israel Institute of Technology.